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 2 
ABSTRACT 24 
A carbapenem-resistant Escherichia coli (ST448) was recovered from a urine 25 
culture of a female patient with no recent travelling record. PCR screening identified the 26 
presence of blaNDM-5, blaTEM-1, blaOXA-1, blaCMY-42 and rmtB. blaNDM-5 was carried in a 27 
conjugative IncFII-type plasmid (90 Kb) together with blaTEM-1 and rmtB. The genetic 28 
surrounding of blaNDM-5 showed structural similarities to those of pMC-NDM and 29 
pGUE-NDM, identified in Poland and France in E. coli of African and Indian origin, 30 
respectively. 31 
 3 
Carbapenemase-producing Enterobacteriaceae (CPE) constitute a public health 32 
problem regarding both hospital and community-acquired infections (1). Despite 33 
increasing reports of CPE in Europe and, predominantly in southern European 34 
countries, the prevalence of CPE in Spain still remains relatively low although is 35 
steadily increasing, with only a few outbreaks or sporadic isolates harboring VIM, KPC, 36 
OXA-48 or NDM-1 being reported (2). After the identification of NDM-1 in a Swedish 37 
traveller returning from India (3), NDM enzymes have gathered special attention due to 38 
their rapid global spread and frequent association with additional resistance genes (4). 39 
There are currently twelve NDM variants (http://www.lahey.org) differing by one or 40 
two amino acid substitutions that may display slightly different hydrolytic capabilities 41 
(4). 42 
The aim of this study was to characterize an NDM-5-producing E. coli recovered 43 
in Spain from a non-traveller patient. 44 
A 78-years-old Spanish Caucasian female with a history of acute pyelonephritis 45 
treated with ceftriaxone (1g/24h) was positive for a carbapenem-resistant E. coli strain 46 
(HC105) in urine 15 days after the end of treatment. The patient was asymptomatic at 47 
this stage. Susceptibility testing using Etest strips (AB-bioMérieux, Solna, Sweden) and 48 
interpreted according to EUCAST guidelines (version 4.0, 2014, http://www.eucast.org) 49 
indicated that HC105 was resistant to all the antibiotics tested except tigecycline, 50 
fosfomycin and colistin (MIC of 0.38 µg/ml, 0.5 µg/ml and 0.125 µg/ml, respectively) 51 
with ertapenem, imipenem and meropenem MICs > 32 µg/ml (Table 1). The patient was 52 
successfully treated with fosfomycin (2g/8h) and no additional CPE were recovered. 53 
Screening of HC105 for carbapenemase/metallo-β-lactamase (MBL)-production yielded 54 
positive results using either the modified Hodge test or imipenem-EDTA Etest strips, 55 
suggesting carriage of an MBL. PCR and sequence analysis for carbapenemase, ESBL, 56 
 4 
and plasmid-mediated AmpC cephalosporinase-encoding genes (5, 6) identified the 57 
presence of blaNDM-5, blaTEM-1, blaOXA-1 and blaCMY-42. Screening for 16S rRNA-methylase 58 
genes (7) also identified the rmtB gene conferring high-level resistance to all 59 
aminoglycosides, in agreement with the susceptibility profile (Table 1). Multilocus 60 
sequence typing (http://mlst.ucc.ie/mlst/dbs/Ecoli) and PCR-based phylogroup analysis 61 
(8) assigned E. coli HC105 to sequence type 448 (ST448) and phylogroup B1, 62 
respectively. 63 
To study the transferability of the resistance phenotype, a biparental mating 64 
between HC105 and E. coli J53AziR was conducted and transconjugants were selected 65 
on LB agar plates containing 1 µg/ml meropenem and 100 µg/ml sodium azide. All 66 
transconjugants acquired resistance to all aminoglycosides and β-lactams tested but 67 
aztreonam (Table 1), concomitant with the acquisition of blaNDM-5, blaTEM-1 and rmtB but 68 
not of blaOXA-1, and blaCMY-42. S1 nuclease–pulsed-field gel electrophoresis (PFGE) (6) 69 
revealed two plasmids of circa 50 and 90kb in HC105 but only a single plasmid of 90kb 70 
in the transconjugant strains. Plasmid replicon typing (9, 10) showed that HC105 71 
contained plasmid-types belonging to IncFII and I1 incompatibility groups while 72 
transconjugant strains had only acquired the IncFII-type. Digoxigenin-labeled probes 73 
against blaNDM-5, blaTEM-1 and rmtB hybridized against blotted nylon membranes from the 74 
S1-PFGE gels matched with the band corresponding to the 90kb plasmid, demonstrating 75 
co-carriage of all three resistance mechanisms in a single conjugative IncFII plasmid of 76 
circa 90kb, designated as pHC105-NDM. 77 
Inverse PCR over genomic DNA from HC105 (6) and DNA sequencing showed 78 
the presence of a remnant ISAba125 sequence immediately upstream from blaNDM-5 as 79 
well as the ble, trpF and tat genes downstream from blaNDM-5 (Fig.1), altogether 80 
comprising a genetic arrangement highly conserved among NDM-producing isolates 81 
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from different Gram-negative species (11). Subsequent PCR mapping of the blaNDM-5 82 
genetic surrounding showed that this region was bracketed by two IS26 insertion 83 
sequences constituting a putative composite transposon also containing an ISCR1 84 
element and a class I integron whose int1 gene was truncated by the downstream IS26 85 
copy. In addition, blaTEM-1 and rmtB were located adjacent to the upstream IS26 copy 86 
(Fig.1).  87 
The genetic surrounding of the blaNDM-5 gene in pHC105-NDM is almost 88 
identical to that of the blaNDM-1 gene present in pMC-NDM (12), which contains an 89 
additional IS26 truncating ISCR1, and is very similar to that of blaNDM-1 in pGUE-NDM 90 
(13), except for the upstream blaTEM-1 and rmtB genes that are missing in pGUE-NDM. 91 
Both pMC-NDM and pGUE-NDM are IncFII plasmids of approximately 90kb that were 92 
identified in Poland and France from E. coli isolates of African and Indian origin and 93 
belonging to ST complexes ST23 and ST131, respectively. 94 
NDM enzymes encoded in IncFII plasmids, with a narrow host range, are being 95 
increasingly reported (12-17), an observation that deserves further attention since IncFII 96 
plasmid scaffolds have been linked to the worldwide spread of CTX-M-15 (18). Of 97 
note, the genetic array blaTEM-1-rmtB-IS26 upstream from blaNDM in both pHC105-NDM 98 
and pMC-NDM has typically been associated with the Tn3 transposon in IncFII 99 
plasmids as well (19-22), and it is not unlikely that linkage of this array with the NDM 100 
module originated from an IS26-mediated recombination event, a common mechanism 101 
in the mobilization and genetic rearrangement of NDM-related structures (13, 14). 102 
In this study we report the molecular characterization of an E. coli (ST448) 103 
clinical isolate carrying a NDM-5 metallo-β-lactamase in a ∼90kb IncFII plasmid, 104 
representing the fourth NDM-producing isolate described in Spain. Previous isolates 105 
carried the NDM-1 variant and were associated with recent travels to India (6, 23, 24), 106 
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while HC105 represents the first NDM-5 reported in Spain and it was recovered from a 107 
non-traveller whose close relatives reported no recent travelling history either, thus 108 
suggesting that it was community-acquired and autochthonous. This is also the first 109 
ST448 E. coli strain harboring an NDM enzyme. Interestingly, blaNDM-5 was harbored by 110 
IncFII-type plasmids in isolates from India and the UK also bearing blaTEM-1 and rmtB 111 
genes, suggesting that blaNDM-5 genes might share a common genetic platform (25, 26).  112 
The nosocomial spread of NDM-producing isolates has only been sporadically 113 
reported and was likely related to particular clonal lineages (17, 27-29). Multiple 114 
reports, however, have identified community-acquired NDM-producing isolates, 115 
suggesting the existence of a hidden reservoir and transmission among colonized 116 
carriers (30). The present study highlights that, while NDM enzymes are still rarely 117 
reported in the clinical setting in Spain, attention should be paid to the prevalence of 118 
NDM enzymes within the community to monitor future trends and prevent their further 119 
spread into epidemic clonal lineages. 120 
The sequence of blaNDM-5 and its genetic environment has been deposited at the 121 
NCBI GenBank under accession number KM598665. 122 
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 245 
FIGURE LEGENDS AND TABLES 246 
Fig. 1. Schematic drawing showing the genetic elements surrounding the 247 
blaNDM genes in pHC105-NDM (KM598665), pMC-NDM (HG003695) and pGUE-248 
NDM (JQ364967). The lengths of the arrows are not proportional to the lengths of the 249 
genes or open reading frames (ORFs). Red arrow indicates the remnant ISAba125 250 
fragment providing the -35 promoter region for transcription of blaNDM. Abbreviations 251 
and symbols are: blaTEM, TEM β-lactamase; rmtB, 16S rRNA methylase gene; IS, 252 
insertion sequence; blaNDM, New Delhi metallo-β-lactamase gene; ble, bleomycin 253 
resistance gene; trpF, phosphoribosylanthranilate isomerase gene; tat, twin-arginine 254 
translocation pathway signal protein gene; sul1, sulfonamide resistance gene; qac, 255 
quaternary ammonium compounds resistance gene; aadA2, aminoglycoside 256 
adenyltransferase gene; orf1, open reading frame; dhfrA12, dihydrofolate reductase 257 
gene; int1, integrase gene; tnpM, transposition modulator gene; aacC2, aminoglycoside 258 
acetyltransferase gene; IRL, inverted repeat left; IRR, inverted repeat right; Tn, 259 
transposon; Δ, truncated gene. 260 
 261 
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Table 1. In vitro susceptibilities of E. coli HC105 and E. coli J53AziR HC105 262 
transconjugant expressing NDM-5 carbapenemase.  263 
Antimicrobial 
Agents 
MIC (µg/ml) in: 
E. coli HC105 E. coli J53 AziR 
HC105T 
E. coli J53AziR 
Cefoxitin > 256 > 256 2 
Cefotaxime > 256 > 256 0.094 
Ceftazidime > 256 > 256 0.25 
Cefepime > 256 128 0.25 
Imipenem > 32 > 32 0.19 
Meropenem > 32 > 32 0.023 
Ertapenem > 32 > 32 0.008 
Aztreonam 64 0.19 0.047 
Gentamicin > 256 > 256 0.19 
Amikacin > 256 > 256 0.75 
Tobramycin > 256 > 256 0.19 
Tigecycline 0.38 0.38 0.38 
Colistin 0.125 0.125 0.125 
Fosfomycin 0.5 0.5 0.5 
Levofloxacin >32 0.047 0.047 
Ciprofloxacin > 32 0.032 0.008 
 264 
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